Table 2.

General Linear Regression Analysis Results of anti-NMDAR Ab level on cognitive performance

	FEP (anti-NMDAR Ab)			HC (anti-NMDAR Ab)
Dependent	β	t	p	β	T	p
MCCB
Speed of Processing	−0.79	−2.37	0.02*	−0.04	−0.15	0.88
Working Memory	−1.16	−4.23	6.01 ×10−5*	−0.45	−1.46	0.15
Verbal Learning	−1.24	−3.92	1.78×10−4*	0.07	0.22	0.83
Attention and Vigilance	−0.71	−1.83	0.07	−1.81	−3.19	0.95
Visual Learning	−0.66	−2.01	0.05	−0.09	−0.36	0.72
R/Problem Solving	−0.30	−0.86	0.39	−0.09	−0.08	0.94
Social Cognition	−0.35	−0.94	0.35	0.02	0.05	0.96
Total score	−0.96	−3.65	4.63×10−4*	−0.22	−0.79	0.44
PANSS
Positive score	0.38	2.55	0.01*	NA	NA	NA
Negative score	0.53	2.94	4.24 ×10−3*	NA	NA	NA
General score	0.13	0.63	0.53	NA	NA	NA
Total score	1.01	2.81	6.13 ×10−3*	NA	NA	NA

Abbreviations: FEP, First Episode Patients with Schizophrenia; HC, Healthy Controls;MCCB, MATRICS Consensus Cognitive Battery; NA, not applicable; PANSS, Positive and Negative Syndrome Scale. General linear regression was used. The source was NMDAR antibody level (ng/ml), the dependents were subscores and total score of MCCB and PANSS, the covariate was age, sex and education, data on the final models were presented.

^*Significant at p<0.05